New Dexcom CGM for People with Type 2 Diabetes Not Using Insulin
By Arvind Sommi
Dexcom has announced the development of a new continuous glucose monitoring system specifically designed for the 25 million Americans with type 2 diabetes who do not require insulin.
Dexcom is set to introduce an innovative CGM system that is tailored to the needs of people with type 2 diabetes who don’t use insulin.
While the specific name and price of the device have not been disclosed, it is designed to provide accurate and continuous glucose monitor (CGM) readings, empowering users to make informed decisions about their health. The new CGM will last for 15 days and have a cash-pay option for those who do not have insurance coverage.
While there are over 25 million people with type 2 diabetes not using insulin, only 5% of those people use a CGM. Dexcom aims to provide a solution by developing a CGM system specifically for this population.
Customized features for people with diabetes who don't use insulin
Dexcom's new CGM system is an adaptation of the G7 and takes into account the unique requirements of non-insulin-using individuals with type 2 diabetes. Users will have access to personal features that assist in optimizing their nutrition and exercise routines, all while minimizing unnecessary alarms and alerts.
According to Dexcom, people with type 2 diabetes are motivated to avoid injectable therapies and insulin, and with this new CGM, they will have the freedom to make informed decisions about how they manage blood sugar.
To learn more about Dexcom CGMs, read our other articles:
